VectivBio Holding AG announced that Wouter Joustra was elected as a new member of the Board of Directors at the Extraordinary General Meeting held on December 9, 2022. Mr. Wouter Joustra brings a breadth of capital markets and investment experience in the life sciences investment industry to VectivBio. He joined Forbion, in October 2019, where he is currently General Partner.

At Forbion, Mr. Joustra is responsible for deal origination, general portfolio management and divestment strategies, and focuses on Forbion's Growth Opportunities Funds, which concentrates on investing in late stage life sciences companies. Previously, Mr. Joustra was a Senior Trader, as well as Executive Board member of the life sciences franchise at Kempen. In this role, Mr. Joustra managed Kempen's trading portfolio, and he was involved in deal structuring and equity capital markets transactions, as well as larger block trades.

Mr. Joustra is currently on the board of Forbion's SPAC vehicle, Forbion European Acquisition Corp., in addition to being a board observer at NewAmsterdam Pharma N.V. Mr. Joustra holds an M.Sc. in Business Administration from the University of Groningen, and a B.Sc. in International Business and Management from this same university.

‘We are pleased to add Wouter to the VectivBio Board of Directors. His deep experience in life-science.